Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to investigate the effects of food on the pharmacokinetics/pharmacodynamics of CKD-519.

Clinical Trial Description

A randomized, open-label, single dose, 1-sequence, 3-treatment, 3-period crossover study to investigate the effects of food on the pharmacokinetics/pharmacodynamics of CKD-519 in healthy male subjects. ;

Study Design

Related Conditions & MeSH terms

NCT number NCT02894541
Study type Interventional
Source Chong Kun Dang Pharmaceutical
Status Completed
Phase Phase 1
Start date August 2016
Completion date January 2017

See also
  Status Clinical Trial Phase
Completed NCT03457649 - IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers Phase 1
Completed NCT00995891 - Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
Active, not recruiting NCT02747927 - Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children Phase 3
Completed NCT03279146 - A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects Phase 1
Completed NCT00995527 - Characterization of the Innate Immune Response in Healthy NIH Employees at Baseline and After Immunization With the H1N1 Vaccine N/A
Completed NCT03662191 - Phase I Safety, Pharmacokinetics and Bioavailability Study Comparing Rate and Extent of Absorption of Two Different Forms of Tafamidis (PF-6291826) Phase 1
Completed NCT03314402 - The Tolerance, Pharmacokinetics of Jaktinib in Healthy Volunteers Phase 1
Completed NCT01136928 - Pharmacokinetic Interaction Study of Efavirenz and American Ginseng in Healthy Volunteers Phase 1
Recruiting NCT03390673 - A Trial to Demonstrate the Equivalent Pharmacokinetic Properties of HD204 and Bevacizumab (Avastin®) in Healthy Male Subjects Phase 1
Enrolling by invitation NCT02796001 - Hallmarks of Protective Immunity in Sequential Rhinovirus Infections in Humans Phase 1/Phase 2
Completed NCT03194139 - A Study Designed to Compare the Safety and Pharmacokinetics of Intravenously Administered Superoxide Dismutase Mimetic GC4711 and GC4419 in Healthy Volunteers Phase 1
Completed NCT03201835 - 5-Way Crossover Study to Compare the Safety, Tolerability and Pharmacokinetics of New Oral Cannabinoid Formulations Administered as Single Doses, With Buccal Sativex®, in Healthy Volunteers Phase 1
Recruiting NCT01851421 - Fat Metabolism and Melanocortin 3 Receptors in African Americans
Completed NCT03276858 - Single and Multiple-Ascending Dose Study of CRN00808 in Healthy Volunteers Phase 1
Recruiting NCT03648892 - Brain Dopamine Function in Human Obesity
Recruiting NCT03169673 - Healthy Lung Study- Development of 3 Tesla MRI Hardware and Software for Helium-3 Gas Imaging of the Lung: Healthy Volunteer Development Study
Recruiting NCT02910973 - Using a Transcutaneous Electrical Auricular Stimulator to Harness the Cholinergic Anti-Inflammatory Pathway N/A
Recruiting NCT02825368 - Homeopathic Vaccine Trial Phase 4
Active, not recruiting NCT02932488 - Cerebral Pharmacodynamic Effects of 5-HT1B Receptor Stimulation Phase 1
Not yet recruiting NCT02880657 - Evaluation of SODB® (Superoxide Dismutase by Bionov®) in the Physical Condition Improvement in Healthy Subjects N/A